C71T
CANCELLED SECTION 71
26/06/2026
Voltar para busca
Dado oficial do USPTO
MELT3
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
21/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
19/10/2018
Data de registro
10/12/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/06/2026
Última transação
21/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
AU
Examinador
EINSTEIN, MATTHEW T
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Invictus Biotechnology Pty Ltd
Representantes
Lindsay J. Hulley Rutan & Tucker, LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Dietary food supplements; dietary nutritional supplements; dietary protein supplements; dietary supplements; dietary supplement drinks for energy; food supplements in the nature of dietary supplements; herbal dietary supplements; plant compounds for use as dietary supplements for medicinal use; plant extracts in the nature of dietary supplements; protein dietary supplements; dietetic food supplements adapted for medical purposes; food supplements for medical purposes; medicated food supplements; medicated preparations for use as supplements for food; medicated supplements for food for humans; medicated supplements for foodstuffs for human consumption; medicinal food supplements; nutritional supplements; nutritional supplements for medical use; protein supplements for humans; nutritional supplements containing trace elements for foodstuffs for human consumption; vitamin preparations in the nature of food supplements; vitamin supplements; vitamin supplements for foodstuffs for human consumption; preparations of vitamins; stimulants made of vitamins for improving exercise performance; dietary supplemental drinks in the nature of vitamin drinks; vitamin preparations; vitamin preparations for human consumption; vitamin preparations in tablet form; vitamin tablets; vitamins; capsules sold empty for medicines; medicines for human purposes for the treatment of muscle injuries and disorders and sports related injuries and for increasing antioxidant levelsmaintaining cholesterol and improving exerciseendurancecapacityperformance and cardiovascular health; medicines for human use for the treatment of muscle injuries and disorders and sports related injuries and for increasing antioxidant levelsmaintaining cholesterol and improving exerciseendurancecapacityperformance and cardiovascular health; medicines for preventing muscle injuries and disorders and sports related injuries and cardiovascular ailments; medicines for treatment of the heart; medicines in tablet form for the treatment of muscle injuries and disorders and sports related injuries and for increasing antioxidant levelsmaintaining cholesterol and improving exerciseendurancecapacityperformance and cardiovascular health; tablets for medicinesdrug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations in the form of tablets for increasing antioxidant levelsmaintaining cholesterol and improving exerciseendurancecapacityperformance and cardiovascular health; pharmaceutical tablets for muscle injuries and disorders and sports related injuries and for increasing antioxidant levelsmaintaining cholesterol and improving exerciseendurancecapacityperformance and cardiovascular health; tablets being pharmaceuticals for increasing antioxidant levelsmaintaining cholesterol and improving exerciseendurancecapacityperformance and cardiovascular health
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/12/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/04/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
24/03/2020
FIMP
FINAL DISPOSITION PROCESSED
24/03/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/03/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
10/12/2019
GPNX
NOTIFICATION PROCESSED BY IB
05/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/09/2019
PUBO
PUBLISHED FOR OPPOSITION
24/09/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/09/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
18/09/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/09/2019
ALIE
ASSIGNED TO LIE
16/08/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/08/2019
RFNP
REFUSAL PROCESSED BY IB
02/03/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/02/2019
RFRR
REFUSAL PROCESSED BY MPU
12/02/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/02/2019
MAFR
APPLICATION FILING RECEIPT MAILED
05/02/2019
CNRT
NON-FINAL ACTION WRITTEN
04/02/2019
DOCK
ASSIGNED TO EXAMINER
01/02/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/02/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
31/01/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MELT3 ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.